Silver Book Fact

Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.

Pyenson, Bruce S., Marcia S. Sander, Yiding Jiang, Howard Kahn, and James L. Mulshine. An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost. Health Aff. 2012; 31(4): 770-779. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2011.0814?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
An Actuarial Analysis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost
Publication
Health Aff
Publisher
Project HOPE
Publication Date
2012
Authors
Pyenson, Bruce S., Marcia S. Sander, Yiding Jiang, Howard Kahn, and James L. Mulshine
Volume & Issue
Volume 31, Issue 4
Pages
770-779
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.  
  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • According to the Pharmaceutical Research and Manufacturers of America, a number of vaccines are being studied that would cause the body’s own immune system to fight cancer after it has…